ST

Steve Tregay

Managing Partner at Mission BioCapital; Chairman of Board, LabCentral

Cambridge, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Drug Discovery
Biotechnology
Pharmaceutical Industry
Drug Design
Drug Development
Medicinal Chemistry
Oncology
Lifesciences
Technology Transfer
Clinical Development
CRO
Cancer
Chemistry
Organic Chemistry
Biopharmaceuticals
Commercialization
Neuroscience
GLP
Biomarkers
Venture Capital

Education

Lists including Steve

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

MB
Mission BioCapital

2019

  • Managing General Partner

    2019

Neuro StealthCo

2020

  • Founder, Interim CEO

    2020

    Accelerating Unique and Transformative Neuroscience

VB
Vedere Bio

2020

  • Board Member

    2020

NT
Nocion Therapeutics, Inc.

2021

  • Board Observer

    2021

FT
FORMA Therapeutics

2008 - 2019

  • Founder, President and CEO

    2008 - 2019

CT
Compass Therapeutics LLC

2015 - 2019

  • Founder and Chairman of the Board of Directors

    2015 - 2019

Novartis Venture Fund

2006 - 2009

  • Managing Director

    2006 - 2009

NI
Novartis Institutes for BioMedical Research (NIBR)

2004 - 2006

  • Executive Director

    2004 - 2006

    Head of Strategic Alliances, Oncology, Ophthalmology, and Technologies

Array BioPharma

2001 - 2004

  • Business Development

    2001 - 2004